IGI Logo

Fischer Medical Ventures is currently trading at upper limit of Rs. 685.55, up by 32.60 points or 4.99% from its previous closing of Rs. 652.95 on the BSE.

The scrip opened at Rs. 672.35 and has touched a high and low of Rs. 685.55 and Rs. 672.35 respectively. So far 61 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 702.35 on 08-Apr-2024 and a 52 week low of Rs. 66.80 on 04-Oct-2023.

Last one week high and low of the scrip stood at Rs. 685.55 and Rs. 533.70 respectively. The current market cap of the company is Rs. 3667.69 crore.

The Institutions and Non-Institutions held 6.75% and 93.24% stake in the company respectively.

Fischer Medical Ventures (formerly known as Fischer Chemic) with its wholly owned subsidiary - Time Medical International Ventures (India) has entered into partnership with BluSim Tech to redefine elderly care. This partnership is aimed at revolutionizing nursing home care globally. Fischer Medical Ventures, renowned for being the first company through its wholly owned subsidiary Time Medical International Ventures (India) to indigenously manufacture advanced high quality, cost-efficient Magnetic Resonance Imaging (MRI) systems in India, continues to spearhead innovation in the MedTech industry. Apart from medical imaging, Fischer Medical Ventures strategically invests into a portfolio of high-tech diagnostic solutions. 

This strategic collaboration with BluSim Tech marks a significant milestone in the Fischer Medical Ventures' journey towards expanding its healthcare portfolio and enhancing its offerings in medical imaging and diagnostics solutions, aiming to redefine healthcare through advanced technologies and unparalleled expertise. 

Fischer Medical Ventures is engaged in the trading of certain grades of Laboratory Chemicals.